The Impact of Chloroprocaine 3% for Ambulatory Foot Surgery on Perioperative Process Costs

Ospedale Regionale Bellinzona e Valli

Status: Completed

Conditions: Impact of Anesthetic Choice on Costs

Treatments: Drug: Chloroprocaine; Drug: Mepivacaine

Study type: Observational

Funder types: Other

Identifiers

NCT02406703

BLV07

Details and patient eligibility

About

Background and Objectives Short acting regional anesthetics have already been successfully employed for peripheral nerve blocks in an ambulatory surgery setting. However, the impact on direct and indirect perioperative costs comparing two different short-acting local anesthetics has not been performed, yet.

Methods In an observational study including 50 patients per group, patient undergoing popliteal block with chloroprocaine 3% or mepivacaine 1.5% for ambulatory minor foot surgery were compared. The primary outcome was the saving of both direct and indirect perioperative costs. Secondary outcomes were block success, onset time and block duration, patient satisfaction and unplanned outpatient visits or readmissions after discharge.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA I-III scheduled for elective, unilateral, ambulant minor foot surgery (percutaneous hallux valgus correction, osteotomies, tenotomies, mallet and hammer toes correction, screws and/or plaques removal)

Exclusion criteria

• known allergy to drugs used in the study;
• coagulopathies, known neuropathy;
• pregnancy;
• chronic pain;
• drug or alcohol abuse;
• psychiatric disease or lack of competence affecting compliance and evidence of ongoing sepsis or local skin / subcutaneous tissues infections in the popliteal fossa.

Trial design

100 participants in 2 patient groups

Chloroprocaine

Description:

Patient undergoing popliteal block with chloroprocaine

Treatment:

Drug: Chloroprocaine

Mepivacaine

Description:

Patient undergoing popliteal block with mepivacaine

Treatment:

Drug: Mepivacaine